Araştırma Makalesi
BibTex RIS Kaynak Göster

Influenza, Pneumococcus, Tetanus, and Herpes Zoster Vaccination Status of Patients Aged 65 Years and Over with Respiratory and Cardiac Problems

Yıl 2023, Cilt: 26 Sayı: 2, 141 - 147, 23.06.2023
https://doi.org/10.5152/JANHS.2023.23307

Öz

Objective: This study was conducted to determine the vaccination status and rates among patients aged 65 and over with respiratory and cardiac problems.

Methods: The sample of this descriptive and sectional study consisted of 244 patients aged 65 and over admitted to the chest and cardiology clinic at a state hospital in Turkey between July
2018 and July 2019. The data were collected using the “Structured Questionnaire Form” prepared to determine the sociodemographic, disease, and vaccination status and rates of the patients.
Mean, SD, number, percentage, and chi-square tests were used to evaluate the data.

Results: Only 11.1% of patients knew about the vaccines that should be administered to those aged 65 or over. The rates of vaccination at the recommended frequency of the patients who were
admitted to the chest outpatient clinics were 26.2% in influenza, 7.4% in pneumococcus, 23.8% in tetanus, and 0.8% in herpes zoster and for those admitted to the cardiology outpatient clinics
were 9% in influenza, 3.2% in pneumococcus, 22.9% in tetanus, and 0.8% in herpes zoster.

Conclusion: Influenza, pneumococcus, tetanus, and herpes zoster vaccination rates of the patients were very low. Therefore, it is recommended to monitor patients aged 65 and over with
respiratory and cardiac problems in terms of vaccination and organize training programs to increase vaccination rates.

Kaynakça

  • 1. Centers for Disease Control and Prevention. Recommended immunizations for adults: by age; 2020. https://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html. Accessed July 31, 2020.
  • 2. Weinberger B. Vaccines for the elderly: current use and future challenges. Immun Ageing. 2018;15(1):3. [CrossRef]
  • 3. Alici DE, Sayiner A, Unal S. Barriers to adult immunization and solutions: personalized approaches. Hum Vaccin Immunother. 2017;13(1):213-215. [CrossRef]
  • 4. Çelik A, Altay H, Azap A, et al. Vaccination of adults with heart failure and chronic heart conditions: expert opinion. Turk Kardiyol Dern Ars. 2018;46(8):723-734. [CrossRef]
  • 5. Infectious Diseases and Clinical Microbiology Speciality Society of Turkey, (EKMUD) [Internet]. Adult Immunization Guide; Vaccination in old age; 2019 [cited 2020 May 13]. Available from: file:///C:/Users/Kodlama7/Downloads/eriskin-bagisiklama-rehberi-v-2-2019.pdf.
  • 6. Lang PO, Aspinall R. Vaccination in the elderly: what can be recommended? Drugs Aging. 2014;31(8):581-599. [CrossRef]
  • 7. Haq K, McElhaney JE. Immunosenescence: influenza vaccination and the elderly. Curr Opin Immunol. 2014;29:38-42. [CrossRef]
  • 8. Trıglav TK, Poljak M. Vaccination indications and limits in the elderly. Acta Dermatovenerol Alp Pannonica Adriat. 2013;22(3):65-70.
  • 9. Polat HH, Oncel S, Turhan O, Akcan A, Eravsar K, Yalcin AN. Influenza vaccination in 65 and over age adults in Antalya/Turkey. Turk J Geriatr. 2012;15(4):371-377.
  • 10. Erdoğdu Hİ, Çatak B. Influenza, pneumococcal and herpes zoster vaccination rates amongst people aged 65 years and older and related factors. Turk J Geriatr. 2018;21(4):498-506. [CrossRef]
  • 11. Ciblak MA, Grip Platformu. Influenza vaccination in Turkey: prevalence of risk groups, current vaccination status, factors influencing vaccine uptake and steps taken to increase vaccination rate. Vaccine. 2013;31(3):518-523. [CrossRef]
  • 12. Bal H, Borekci G. Investigation of adult vaccination status and effecting factors in people 65 years and over registered to a family health center in Mersin city. IMJ. 2016;17(4):121-130.
  • 13. Yigitbas BA, Satici C, Tanriverdi E, Gündüz C. Influenza vaccination frequency and associated factors among elderly population, a descriptive study. Turk J Geriatr. 2018;21(4):490-497.
  • 14. Yuruyen M, Ayan G, Demirdag F, et al. Why is vaccination frequency low in elderly patients? Vaccination in elderly patients. J Clin Anal Med. 2018;9(2):138-142.
  • 15. Akman M, Sarısoy M, Uzuner A. The vaccination status and knowledge level of vaccines among adults over the age of sixty-five. J Turk Fam Phys. 2014;5(3):19-23.
  • 16. İlhan B, Bakkaloğlu OK. Vaccination rates in geriatric outpatient clinic in Gaziantep Dr. Ersin Arslan training and research hospital. Haseki. 2019;57(1):75-78. [CrossRef]
  • 17. Mutlu HH, Coşkun FO, Sargın M. The incidence and awareness of vaccination among people aged 65 and over applied to a family medicine outpatient clinic. Ank Med J. 2018;1:1-13. [CrossRef]
  • 18. Johnson DR, Nichol KL, Lipczynski K. Barriers to adult immunization. Am J Med. 2008;121(7):S28-S35. [CrossRef]
  • 19. Schneeberg A, Bettinger JA, McNeil S, et al. Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigation. BMC Public Health. 2014;14(1):442. [CrossRef]
  • 20. Nowalk MP, Zimmerman RK, Shen S, Jewell IK, Raymund M. Barriers to pneumococcal and influenza vaccination in older community-dwelling adults (2000-2001). J Am Geriatr Soc. 2004;52(1):25-30. [CrossRef]
  • 21. Li C, Gubbins PO, Chen GJ. Prior pneumococcal and influenza vaccinations and in-hospital outcomes for community-acquired pneumonia in elderly veterans. J Hosp Med. 2015;10(5):287-293. [CrossRef]
  • 22. Mangen MJJ, Rozenbaum MH, Huijts SM, et al. Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands. Eur Respir J. 2015;46(5):1407-1416. [CrossRef]
  • 23. McKinney WP, Barnas GP. Influenza immunization in the elderly: knowledge and attitudes do not explain physician behavior. Am J Public Health. 1989;79(10):1422-1424. [CrossRef]
  • 24. Nitsch-Osuch A, Gołębiak I, Wyszkowska D, et al. Influenza vaccination coverage among polish patients with chronic diseases. Adv Exp Med Biol. 2017;968:19-34. [CrossRef]
  • 25. Balbay EG, Tanrıverdi E, Alasan F, Suner KO. The frequency of vaccination in patients with chronic obstructive pulmonary disease in Düzce. Journal of Duzce University Health Sciences Institute. 2013;3(2):15-17.
  • 26. Ciftci F, Sen E, Demir N, Kayacan O. What do patients know about pneumococcal vaccine? Journal of Ankara University Faculty Medicine. 2017;70(2):91-96.
  • 27. Bolatkale MK, Kutlu R, Eryılmaz MA. The adult ımmunization knowledges and vaccination status of ındividuals who applied to family medicine. Konuralp Med J. 2019;11(3):362-368.
  • 28. Vaccine uptake in Canadian adults [Internet]. Highlights from the Adult National Immunization Coverage Survey (aNICS); 2016. https://www.canada.ca/en/services/health/publications/healthy-living/2016-vaccine-uptakecanadian-adults-survey.html. Accessed 2020 February 16.
  • 29. Kimberly A, Wynne M. Flu shots and the characteristics of unvaccinated Medicare beneficiaries. Medicare Medicaid Res Rev. 2011;1(4):1-11

Solunum ve Kardiyak Sorunları Olan 65 Yaş ve Üzeri Hastaların İnfluenza, Pnömokok, Tetanoz, Herpes Zoster Aşılanma Özellikleri

Yıl 2023, Cilt: 26 Sayı: 2, 141 - 147, 23.06.2023
https://doi.org/10.5152/JANHS.2023.23307

Öz

Amaç: Bu araştırma, solunum ve kardiyak sorunları olan 65 yaş ve üzeri hastaların aşı özellikleri ile aşılanma oranlarını belirlemek amacıyla yapıldı.

Yöntemler: Tanımlayıcı ve kesitsel tipteki araştırmanın örneklemini Temmuz 2018-Temmuz 2019 tarihleri arasında bir devlet hastanesinin göğüs ve kardiyoloji polikliniğine başvuran 65 yaş
ve üzeri toplam 244 hasta oluşturdu. Veriler, hastaların sosyodemografik, hastalık ve aşılanma özellikleri ile aşılanma oranlarını belirlemek amacıyla hazırlanan “Yapılandırılmış Soru Formu” ile
toplandı. Verilerin değerlendirilmesinde ortalama, standart sapma, sayı, yüzde ve ki-kare testi kullanıldı.

Bulgular: Hastaların sadece %11,1’i 65 yaş ve üzerinde uygulanması gereken aşıları bilmekte idi. Aşılanan hastaların önerilen sıklıkta aşı yaptırma oranları göğüs polikliniklerine başvuranlarda;
influenza %26,2, pnömokok %7,4, tetanoz %23,8 ve herpes zoster %0,8’dir. Kardiyoloji polikliniklerine başvuranlarda; influenza %9, pnömokok %3,2, tetanoz %22,9 ve herpes zoster %0,8’dir.

Sonuç: Hastaların influenza, pnömokok, tetanoz ve herpes zoster aşılanma oranları oldukça düşüktür. Bu nedenle solunum ve kardiyak sorunları olan 65 yaş ve üzeri hastaların aşılanma
açısından izlenmesi ve aşılanma oranlarının arttırılmasına yönelik eğitimlerin düzenlenmesi önerilir.

Kaynakça

  • 1. Centers for Disease Control and Prevention. Recommended immunizations for adults: by age; 2020. https://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html. Accessed July 31, 2020.
  • 2. Weinberger B. Vaccines for the elderly: current use and future challenges. Immun Ageing. 2018;15(1):3. [CrossRef]
  • 3. Alici DE, Sayiner A, Unal S. Barriers to adult immunization and solutions: personalized approaches. Hum Vaccin Immunother. 2017;13(1):213-215. [CrossRef]
  • 4. Çelik A, Altay H, Azap A, et al. Vaccination of adults with heart failure and chronic heart conditions: expert opinion. Turk Kardiyol Dern Ars. 2018;46(8):723-734. [CrossRef]
  • 5. Infectious Diseases and Clinical Microbiology Speciality Society of Turkey, (EKMUD) [Internet]. Adult Immunization Guide; Vaccination in old age; 2019 [cited 2020 May 13]. Available from: file:///C:/Users/Kodlama7/Downloads/eriskin-bagisiklama-rehberi-v-2-2019.pdf.
  • 6. Lang PO, Aspinall R. Vaccination in the elderly: what can be recommended? Drugs Aging. 2014;31(8):581-599. [CrossRef]
  • 7. Haq K, McElhaney JE. Immunosenescence: influenza vaccination and the elderly. Curr Opin Immunol. 2014;29:38-42. [CrossRef]
  • 8. Trıglav TK, Poljak M. Vaccination indications and limits in the elderly. Acta Dermatovenerol Alp Pannonica Adriat. 2013;22(3):65-70.
  • 9. Polat HH, Oncel S, Turhan O, Akcan A, Eravsar K, Yalcin AN. Influenza vaccination in 65 and over age adults in Antalya/Turkey. Turk J Geriatr. 2012;15(4):371-377.
  • 10. Erdoğdu Hİ, Çatak B. Influenza, pneumococcal and herpes zoster vaccination rates amongst people aged 65 years and older and related factors. Turk J Geriatr. 2018;21(4):498-506. [CrossRef]
  • 11. Ciblak MA, Grip Platformu. Influenza vaccination in Turkey: prevalence of risk groups, current vaccination status, factors influencing vaccine uptake and steps taken to increase vaccination rate. Vaccine. 2013;31(3):518-523. [CrossRef]
  • 12. Bal H, Borekci G. Investigation of adult vaccination status and effecting factors in people 65 years and over registered to a family health center in Mersin city. IMJ. 2016;17(4):121-130.
  • 13. Yigitbas BA, Satici C, Tanriverdi E, Gündüz C. Influenza vaccination frequency and associated factors among elderly population, a descriptive study. Turk J Geriatr. 2018;21(4):490-497.
  • 14. Yuruyen M, Ayan G, Demirdag F, et al. Why is vaccination frequency low in elderly patients? Vaccination in elderly patients. J Clin Anal Med. 2018;9(2):138-142.
  • 15. Akman M, Sarısoy M, Uzuner A. The vaccination status and knowledge level of vaccines among adults over the age of sixty-five. J Turk Fam Phys. 2014;5(3):19-23.
  • 16. İlhan B, Bakkaloğlu OK. Vaccination rates in geriatric outpatient clinic in Gaziantep Dr. Ersin Arslan training and research hospital. Haseki. 2019;57(1):75-78. [CrossRef]
  • 17. Mutlu HH, Coşkun FO, Sargın M. The incidence and awareness of vaccination among people aged 65 and over applied to a family medicine outpatient clinic. Ank Med J. 2018;1:1-13. [CrossRef]
  • 18. Johnson DR, Nichol KL, Lipczynski K. Barriers to adult immunization. Am J Med. 2008;121(7):S28-S35. [CrossRef]
  • 19. Schneeberg A, Bettinger JA, McNeil S, et al. Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigation. BMC Public Health. 2014;14(1):442. [CrossRef]
  • 20. Nowalk MP, Zimmerman RK, Shen S, Jewell IK, Raymund M. Barriers to pneumococcal and influenza vaccination in older community-dwelling adults (2000-2001). J Am Geriatr Soc. 2004;52(1):25-30. [CrossRef]
  • 21. Li C, Gubbins PO, Chen GJ. Prior pneumococcal and influenza vaccinations and in-hospital outcomes for community-acquired pneumonia in elderly veterans. J Hosp Med. 2015;10(5):287-293. [CrossRef]
  • 22. Mangen MJJ, Rozenbaum MH, Huijts SM, et al. Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands. Eur Respir J. 2015;46(5):1407-1416. [CrossRef]
  • 23. McKinney WP, Barnas GP. Influenza immunization in the elderly: knowledge and attitudes do not explain physician behavior. Am J Public Health. 1989;79(10):1422-1424. [CrossRef]
  • 24. Nitsch-Osuch A, Gołębiak I, Wyszkowska D, et al. Influenza vaccination coverage among polish patients with chronic diseases. Adv Exp Med Biol. 2017;968:19-34. [CrossRef]
  • 25. Balbay EG, Tanrıverdi E, Alasan F, Suner KO. The frequency of vaccination in patients with chronic obstructive pulmonary disease in Düzce. Journal of Duzce University Health Sciences Institute. 2013;3(2):15-17.
  • 26. Ciftci F, Sen E, Demir N, Kayacan O. What do patients know about pneumococcal vaccine? Journal of Ankara University Faculty Medicine. 2017;70(2):91-96.
  • 27. Bolatkale MK, Kutlu R, Eryılmaz MA. The adult ımmunization knowledges and vaccination status of ındividuals who applied to family medicine. Konuralp Med J. 2019;11(3):362-368.
  • 28. Vaccine uptake in Canadian adults [Internet]. Highlights from the Adult National Immunization Coverage Survey (aNICS); 2016. https://www.canada.ca/en/services/health/publications/healthy-living/2016-vaccine-uptakecanadian-adults-survey.html. Accessed 2020 February 16.
  • 29. Kimberly A, Wynne M. Flu shots and the characteristics of unvaccinated Medicare beneficiaries. Medicare Medicaid Res Rev. 2011;1(4):1-11
Toplam 29 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Halk Sağlığı Hemşireliği, Yaşlı Bakımı Hemşireliği, Sağlık Hizmetleri ve Sistemleri (Diğer)
Bölüm Araştırma Makaleleri
Yazarlar

Elif Okur Bu kişi benim 0000-0003-2608-8584

Sevilay Hintistan Bu kişi benim 0000-0002-5907-5723

Yağmur Akbal Bu kişi benim 0000-0001-6748-6701

Yayımlanma Tarihi 23 Haziran 2023
Yayımlandığı Sayı Yıl 2023 Cilt: 26 Sayı: 2

Kaynak Göster

AMA Okur E, Hintistan S, Akbal Y. Influenza, Pneumococcus, Tetanus, and Herpes Zoster Vaccination Status of Patients Aged 65 Years and Over with Respiratory and Cardiac Problems. Journal of Nursology. Haziran 2023;26(2):141-147. doi:10.5152/JANHS.2023.23307

31408